Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNL.L Share News (DNL)

  • There is currently no data for DNL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Stocks-Factors to watch on March 12

Mon, 12th Mar 2018 05:17

March 12 (Reuters) - Britain's FTSE 100 index is seen opening up 8points higher at 7,233 on Monday, according to financial bookmakers. * GKN-MELROSE: GKN has struck a $6.1 billion deal to merge itsautomotive business with U.S. company Dana Incorporated in a move by theBritish engineer to fend off a hostile takeover by turnaround specialist MelroseIndustries. * RECKITT BENCKISER: Reckitt Benckiser has no regrets about its $17billion acquisition of Mead Johnson last year, its chief executive said, eventhough there are concerns it may now be too stretched to buy Pfizer's PFE.Ncoveted consumer health business. * SAUDI ARAMCO IPO: British officials have been informed by their Saudicounterparts that oil giant Saudi Aramco's IPO-ARMO.SE initial public offeringis likely to be delayed until 2019, the Financial Times reported. * GOLD: Gold prices were steady on Monday as the U.S. dollar inched lower,with the latest U.S. jobs report easing fears of inflation and faster U.S. ratehikes. * OIL: Oil markets edged up on Monday on the back of a drop in the number ofU.S. rigs drilling for more production and as the U.S. economy continued tocreate jobs, which industry hopes will drive higher fuel demand. * The UK blue chip FTSE 100 index closed 0.3 percent higher at7,224.51 points on Friday, joining in a broader equity rally followingsupportive U.S. jobs data which calmed investor nerves over tighter monetarypolicy. * For more on the factors affecting European stocks, please click on: cpurl://apps.cp./cms/?pageId=livemarkets * UK CORPORATE DIARY: Polymetal International Full Year 2017 Earnings Release Diurnal Group PLC Half Year 2018 Earnings Release TODAY'S UK PAPERS > Financial Times > Other business headlines Multimedia versions of Reuters Top News are now available for: * 3000 Xtra : visit http://topnews.session.rservices.com * For Top News : http://topnews.reuters.com (Reporting by Siju Varghese)
More News
25 Jul 2018 09:39

IP Group Swings To Loss In First-Half On Reduction In Portfolio Gains

LONDON (Alliance News) - IP Group PLC on Wednesday said it saw a swing to loss in the first half of 2018 despite an improvement in its portfolio valuation.The intellectual property-based to

Read more
18 Jun 2018 16:22

Abcam Appoints Former Celltech CFO As Non-Executive Chairman

LONDON (Alliance News) - Life sciences company Abcam PLC said Monday it has appointed the former chief financial officer of Celtech Group PLC as a non-executive chairman.Peter Allen is a at

Read more
3 Apr 2018 16:19

Diurnal To Raise GBP10.5 Million Via Share Placing (ALLISS)

LONDON (Alliance News) - Diurnal Group PLC said on Tuesday that it intends to raise GBP10.5 million through the placing of different types of shares.The

Read more
20 Mar 2018 18:28

Diurnal Nets GBP500,000 From Broker Option Exercise (ALLISS)

LONDON (Alliance News) - Pharmaceutical firm Diurnal Group PLC on Tuesday said that it has received a letter of notice to exercise the broker option in respect of 263,157 in

Read more
12 Mar 2018 13:51

UPDATE: Diurnal Prepares For First Revenue As Appoints Trial Partner

LONDON (Alliance News) - Pharmaceutical firm Diurnal Group PLC on Monday appointed a clinical trial services provider for its Chronocort treatment, as it posted a widened loss

Read more
12 Mar 2018 10:18

Diurnal Interim Loss Widens On Cost Rise As Prepares For First Revenue

LONDON (Alliance News) - Pharmaceutical firm Diurnal Group PLC said Monday its interim loss widened amid a rise in research and administrative expenses, as it prepares to its

Read more
25 Jan 2017 09:31

Diurnal Agrees Two Deals With UDG Healthcare Ahead Of Infacort Launch

Read more
17 Jan 2017 15:43

DIRECTOR DEALINGS: Diurnal Non-Executive Ups Interest

Read more
16 Jan 2017 15:08

Director dealings: Diurnal trio dip in after EMA submission in December

(ShareCast News) - A trio of Diurnal Group directors bought shares in the hormone disease specialist, which remain little higher than the low reached late last year. Chairman Peter Allen bought 40,000 shares at 105p and non-executive directors Sam Williams and John Goddard bought 9,248 each at a pri

Read more
12 Jan 2017 09:04

Diurnal Hires Outgoing Mereo BioPharma Finance Chief Bungay

Read more
20 Dec 2016 12:23

Diurnal Submits European Marketing Application For Infacort

Read more
21 Nov 2016 09:32

Diurnal Doses First Testosterone Replacement Therapy Trial Patients

Read more
5 Oct 2016 15:09

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
11 Jul 2016 08:00

Diurnal and IP Group eye 2017 launch for childhood hormonal treatment

(ShareCast News) - Diurnal Group, 45%-owned by university spin-out specialist IP Group, has produced positive clinical trial results for its treatment for a rare hormonal disease in young children. A European Phase III study for AIM-quoted Diurnal's Infacort treatment for paediatric Adrenal Insuffic

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.